INTRODUCTION
============

Development of the organs and tissues that make up multicellular organism is mediated by a series of compartmentalizations from unspecified germ layers of the post-gastrula embryo. During the divergent development that gives rise distinct tissues with defined size and shape from a uniform germ layer continuum, each compartment maintains a unique growth rate relative to its neighboring compartments ([@b62-molce-41-4-257]). The growth of individual tissue compartments is mainly related to the proliferation of the cells that comprise that compartment, whereas intercellular communication mediated by various morphogens and growth factors is responsible for coordination of growth between neighboring tissue compartments. Therefore, both alterations in intrinsic growth rate within a compartment and perturbations in growth coordination between neighboring compartments cause tissue hypertrophy and hypotrophy, resulting in various developmental defects.

DIVERGENT DEVELOPMENT OF OPTIC COMPARTMENTS IN THE NEUROEPITHELIAL CONTINUUM
============================================================================

Vertebrate eyes have been employed to study intercellular and intracellular signaling pathways that specify the fates of optic compartments by inducing compartment-specific transcription factors and coordinate growth of neighboring compartments by regulating cell proliferation ([@b17-molce-41-4-257]; [@b25-molce-41-4-257]; [@b33-molce-41-4-257]). The primordial eye field in the anterior neural plate is specified immediately after gastrulation to form the optic vesicle (OV), a neuroepithelial evagination of the ventral-lateral diencephalic area. The OV then invaginates to form a double-layered optic cup (OC), the inner and outer layers of which develop into the neural retina and the retinal pigment epithelium (RPE), respectively. At the peripheral region of the OC, which forms the border between the retina and RPE, the ciliary margin (CM) is specified and develops further into the ciliary body (CB) and iris in the mature eye ([@b6-molce-41-4-257]; [Fig. 1](#f1-molce-41-4-257){ref-type="fig"}).

Each optic neuroepithelial compartment has discrete growth and proliferation features ([@b17-molce-41-4-257]; [@b25-molce-41-4-257]; [@b33-molce-41-4-257]). The retina has greater proliferative potential than the other two compartments by virtue of the presence of retinal progenitor cells (RPCs), which are capable of dividing repeatedly and generating retinal neurons and Müller glia on distinct developmental schedules. In contrast, the RPE consists of post-mitotic epithelial cells that establish a monolayer structure that enwraps the retina ([@b23-molce-41-4-257]). Cells in the embryonic CM and post-natal CB maintain their proliferative potential even as cells in the retina stop proliferating, albeit at a lower rate than retinal cells ([@b53-molce-41-4-257]; [Fig. 2](#f2-molce-41-4-257){ref-type="fig"}). Proliferating cells in the CM can also be specified to RPCs in the peripheral retina, although the retinal stem cell property of these cells in the mammalian eye remains a matter of debate ([@b7-molce-41-4-257]; [@b19-molce-41-4-257]; [@b46-molce-41-4-257]; [@b55-molce-41-4-257]; [@b65-molce-41-4-257]). Therefore, not only the CB and iris, which arise from the CM domain, but also the retina, fail to grow to normal size when CM cell proliferation is impaired. Defects in CM/CB cell proliferation, therefore, often manifest as microphthalmia.

EXTERNAL FACTORS THAT SPECIFY AND MAINTAIN THE CM COMPARTMENTS IN THE OPTIC NEUROEPITHELIAL CONTINUUM
=====================================================================================================

Multiple signaling pathways that influence the specification and growth of the CM and CB have been identified ([Fig. 2](#f2-molce-41-4-257){ref-type="fig"}). Wnt signaling activity, as determined by Tcf7l1-dependent reporter gene expression, is concentrated in the CM area, particularly in the outer CM layer ([@b22-molce-41-4-257]; [@b43-molce-41-4-257]). Inactivation of Wnt signaling by deletion of β-catenin (βCtn) results in transformation of the CM and RPE into the retina as a result of failure to specify and/or maintain the CM and RPE ([@b24-molce-41-4-257]; [@b69-molce-41-4-257]). Conversely, constitutive activation of Wnt-βCtn signaling leads to expansion of the CM domain into retinal territory ([@b16-molce-41-4-257]; [@b44-molce-41-4-257]). These observations therefore suggest that active Wnt-βCtn signaling is necessary to maintain CM fate, whereas normal eye development requires that Wnt signaling be inhibited in central OC regions (i.e., the retina and RPE).

In addition to Wnts, autocrine bone morphogenic factors (BMPs) are also necessary for development of the CB. Unlike Wnts, which maintain CM identity in the embryo, BMPs mainly act to induce CB folds in the post-natal eyes. Support for this, a haplodeficiency of *Bmp4* or inactivation of BMP signaling by overexpression of the BMP antagonist, Noggin-1, in the lens significantly inhibits the growth of mouse CB ([@b14-molce-41-4-257]; [@b76-molce-41-4-257]). BMP signals are not only delivered by Smad proteins in the ciliary epithelium (CE) comprising the CB, they also crosstalk with Notch signaling ([@b77-molce-41-4-257]). Among multiple Notch receptor and ligand isoforms, Notch2 is expressed in the outer CE layer, whereas its ligand Jagged-1 is expressed in the inner CE layer, enabling Notch signaling from inner to outer CB layers during post-natal CB growth ([@b77-molce-41-4-257]). Conversely, Notch1 activation in the inner CB layer by ligands in the outer CB layer might also possibly coordinate CB growth, given that RPE-to-RPC Notch signaling is known to act in the central OC ([@b27-molce-41-4-257]).

Sonic hedgehog (Shh) is secreted by retinal ganglion cells (RGCs), the first-born retinal neuron subtype, and can diffuse to act on CM cells, while it induces RPC proliferation in the retina ([@b68-molce-41-4-257]). However, the mitogenic effects of Shh cannot reach the CM because Shh is captured and endocytosed by low-density lipoprotein-related protein 2 (Lrp2) in CM cells ([@b18-molce-41-4-257]). Collectively, these intercellular signaling pathways coordinately regulate the proliferation (positively by Wnt and Notch, but negatively by Lrp2) and morphogenesis (positively by BMP) of CM/CB during eye development. However, given the shared, but graded, characteristics of the retina, CM/CB and RPE in terms of proliferation, differentiation and stiffness, additional determinants that are commonly displayed, but to different degrees, in all compartments should be present to allow differentiation of these characteristics. However, given the shared characteristics of the retina, CM/CB and RPE, in terms of proliferation, differentiation and stiffness, additional determinants that are commonly displayed, but to different degrees, in all compartments should be present to allow differentiation of these characteristics.

TISSUE GROWTH CONTROL BY THE HIPPO SIGNALING PATHWAY
====================================================

The Hippo signaling pathway was originally identified in *Drosophila* as a potent mechanism that regulates organ and tissue growth ([@b72-molce-41-4-257]). The Hippo signaling pathway consists of a kinase cascade comprising the Ste20-like kinase Hippo (Hpo), the adaptor protein Salvador (Sav), and the NDR family kinase Warts (Wts) ([@b29-molce-41-4-257]; [@b64-molce-41-4-257]; [@b66-molce-41-4-257]; [@b71-molce-41-4-257]). The Hpo-Sav complex phosphorylates and activates Wts, which in turn phosphorylates the oncoprotein yorkie (Yki), thereby excluding it from the nucleus ([@b30-molce-41-4-257]; [@b36-molce-41-4-257]). Inactivation of Hippo pathway components or over-expression of Yki results in tissue hyperplasia, characterized by excessive cell proliferation and diminished apoptosis. Hippo pathway components are highly conserved from *Drosophila* to humans. The homologs of Hpo (mammalian STE20-like protein kinase 1/2, MST1/2), Sav (Salvador family WW domain-containing protein 1 \[WW45\]), Wts (large tumor suppressor 1/2 \[LATS1/2\]), and Yki (Yes-associated protein \[YAP\] and transcriptional coactivator with PDZ-binding motif \[TAZ\]) constitute an analogous pathway in mammals ([@b32-molce-41-4-257]; [@b36-molce-41-4-257]; [@b61-molce-41-4-257]; [@b63-molce-41-4-257]; [@b64-molce-41-4-257]).

Hippo signaling is activated by contact-dependent signals. Thus, many upstream regulators of Hippo signaling pathway, including Expanded (Ex), Merlin (Mer) and Kibra, are commonly involved in polarization and adhesion of the epithelium. In *Drosophila*, these cytoskeleton-interacting proteins are located at the cell cortex and provide a scaffold for Hippo signaling kinases. Ex proteins activate Hippo signaling through interactions with the transmembrane proteins Crumbs and Fat, which are crucial for maintaining apico-basal and planar cell polarity, respectively ([@b8-molce-41-4-257]; [@b15-molce-41-4-257]; [@b26-molce-41-4-257]; [@b56-molce-41-4-257]). Scribble (SCRIB) binds to Fat and recruits and activates MST1/2 and LATS1/2 ([@b49-molce-41-4-257]; [@b67-molce-41-4-257]). At adherens junctions (AJs) in the epithelium, the immunoglobulin domain-containing cell adhesion protein Echinoid (Ed) activates Hippo signaling by interacting with Sav ([@b73-molce-41-4-257]), whereas cadherins recruit Mer and Kibra via α-catenin to activate Hippo pathway ([@b35-molce-41-4-257]). Alternatively, protein tyrosine phosphatase non-receptor type 14 (PTPN14), angiomotin (AMOT) and α-catenin have been shown to sequester YAP/TAZ at cell junctions to activate Hippo signaling ([@b13-molce-41-4-257]; [@b31-molce-41-4-257]; [@b45-molce-41-4-257]; [@b57-molce-41-4-257]).

NEUROFIBROMIN 2, AN UPSTREAM REGULATOR OF HIPPO SIGNALING PATHWAY
=================================================================

Neurofibromin 2 (NF2), also known as schwannomin, is a mammalian homolog of *Drosophila* Mer that is predominantly expressed in vertebrate nervous tissues ([@b40-molce-41-4-257]). Various NF2 mutants are associated with the human autosomal-dominant disorder, neurofibromatosis type-2, which is characterized by the occurrence of noncancerous tumors in the nervous system ([@b3-molce-41-4-257]). NF2 functions as a tumor suppressor by facilitating the contact-dependent inhibition of cell proliferation ([@b20-molce-41-4-257]). NF2 is homologous to ERM (ezrin/radixin/moesin) family actin-binding proteins, and can serve as a linker between plasma membrane components and the actin cytoskeleton ([@b11-molce-41-4-257]). NF2 has also been shown to integrate extracellular-to-intracellular signaling by interacting with various intracellular proteins ([@b21-molce-41-4-257]). In particular, NF2 is known as a regulator of the Hippo signaling pathway.

NF2 activates the Hippo signaling pathway at multiple levels. First, NF2 initiates Hippo signaling via MST kinases ([@b28-molce-41-4-257]). Specifically, NF2 recruits MST1/2 to form an MST--SAV complex, which phosphorylates LATS. Second, at AJs, NF2 activates LATS independently of MST by associating with α-catenin and AMOT, which recruits LATS kinases ([@b41-molce-41-4-257]). Last, NF2 inhibits the E3 ubiquitin ligase CRL4-DCAF1 to inhibit CRL4-DCAF1-mediated ubiquitination of LATS kinases ([@b39-molce-41-4-257]).

THE HIPPO PATHWAY IN OPTIC COMPARTMENTS
=======================================

YAP/TAZ (YAP and TAZ) is expressed in all optic neuroepithelial compartments; however, its importance varies according to tissue type. In zebrafish, germ-line knockout of *yap/taz* leads to RPE agenesis and coloboma ([@b48-molce-41-4-257]), whereas the expression of constitutively active *yap(5SA)* augments eye pigmentation ([@b2-molce-41-4-257]). Deletion of *Yap* in mouse OV (*Yap^f/f^;Rx-Cre* mice) also results in trans-differentiation of the RPE into retina ([@b34-molce-41-4-257]). However, the ectopic retina is unable to develop a normal morphology, because the loss or knockdown of *Yap* decreases the proliferation of RPCs and simultaneously enhances neuronal differentiation, resulting in precocious depletion of RPC population ([@b34-molce-41-4-257]; [@b75-molce-41-4-257]). Ablation of *Yap*/*Taz* in mouse primordial RPE (*Yap^f/f^;Taz^f/f^;TRP1-Cre* mice) also leads to fate transition into a retina-like population ([@b51-molce-41-4-257]). The severity of the phenotype varies depending on the remaining number of *Yap/Taz* alleles (*Moon et al., unpublished*). Deletion of *Yap*/*Taz* in the specified RPE (*Yap^f/f^;Taz^f/f^;MART1-Cre* mice) or the retina (*Yap^f/f^;Taz^f/f^;Chx10-Cre* mice), however, leads to hypoplasia of the cells without fate transition ([@b51-molce-41-4-257]; *Yap^f/f^;Taz^f/f^;Chx10-Cre mouse results are unpublished*). *Yap/Taz*-deficient RPCs also exhibit aberrant differentiation ([@b51-molce-41-4-257]), consistent with the observations in the *Yap*-deficient lens that show precocious differentiation of lens progenitor cells, disrupted lens epithelial cell polarity, and increased apoptosis ([@b60-molce-41-4-257]). Collectively, these observations indicate that Yap/Taz is necessary for the maintenance of progenitor populations in the retina and RPE that supports the growth of optic neuroepithelial compartments during development.

NF2 REGULATES THE GROWTH OF THE RPE AND CM
==========================================

In mouse eye development, *Nf2* promoter activity is robust in the lens and RPE, but is weak in the retina ([@b1-molce-41-4-257]). Mice lacking the *Nf2* gene specifically in the lens epithelium and embryonic neuroepithelium exhibit malformations in lens structure and the anterior segment of the eye, respectively ([@b70-molce-41-4-257]; [@b74-molce-41-4-257]). In agreement with these reports in mice, human neurofibromatosis type-2 patients acquire anterior ocular lesions, such as colobomatous microphthalmia and juvenile cataracts ([@b47-molce-41-4-257]; [@b50-molce-41-4-257]). These patients also suffer from hypertrophies in posterior parts of the eye, including the epiretinal membrane ([@b9-molce-41-4-257]; [@b37-molce-41-4-257]; [@b47-molce-41-4-257]), as well as combined pigment epithelial and retinal hamartomas (CPERH) ([@b9-molce-41-4-257]; [@b59-molce-41-4-257]), and optic nerve sheath meningiomas ([@b9-molce-41-4-257]; [@b10-molce-41-4-257]).

Recently, we reported that the NF2-Hippo pathway limits the growth capacity of the RPE and CM in the developing eye ([@b51-molce-41-4-257]). Loss of *Nf2* in the mouse optic neuroepithelium leads to microphthalmia and ocular lesions, defects similar to those found in human neurofibromatosis type-2 patients. These abnormal eye morphologies mostly result from overgrowth of the pigmented cell population in the uveal tract. Selective ablation of *Nf2* in the embryonic CM/RPE population (*Yap^f/f^;Taz^f/f^;TRP1-Cre* mice) also results in expansion of those populations, indicating that NF2 restricts the proliferation of optic neuroepithelial derivatives. These ocular lesions are phenocopied by inactivation of *Lats1/2* in the CM and RPE ([@b51-molce-41-4-257]), implying that inactivation of the Hippo pathway mediates the defects in *Nf2-cko* mice. In support of this, *Nf2*-deficient CM and RPE show elevated nuclear localization of Yap/Taz proteins. Furthermore, heterozygous deletion of *Yap* and *Taz* in the *Nf2*-deficient CM and RPE significantly suppresses the hyperplasic phenotypes, suggesting that NF2 supports CM and RPE development by maintaining proper Hippo signaling activity in these populations ([@b51-molce-41-4-257]).

OPTIC COMPARTMENT-SPECIFIC REGULATION OF NF2 EXPRESSION
=======================================================

NF2 has been amply demonstrated to exert an anti-proliferative function in various progenitor populations and is known to mediate the Hippo pathway ([@b38-molce-41-4-257]; [@b58-molce-41-4-257]; [@b74-molce-41-4-257]). Thus, the differential expression of *NF2* along the optic neuroepithelial continuum might generate the observed gradients of Hippo signaling activity and cell proliferation rate in the optic field. Interestingly, *Nf2* is a target gene of the YAP-TEAD transcription activator complex ([@b52-molce-41-4-257]) and *Nf2* expression was significantly reduced in *Yap/Taz*-deficient mouse CM ([@b51-molce-41-4-257]). This therefore establishes an NF2-Hippo-YAP/TAZ feedback circuit, especially in the CM where nuclear Yap is enriched and sustains growth in the post-natal mouse eye ([@b51-molce-41-4-257]).

In the other two optic neuroepithelial compartments---RPE and retina---the two compartment-specific transcription factors Mitf and Sox2 are suggested to control *Nf2* expression. Mitf activates *Nf2* transcription in the RPE by binding directly to its conserved target sequences in the *Nf2* promoter; thus, NF2 expression is eliminated from the RPE of *Mitf^mi-vga9/mi-vga9^* mice ([@b51-molce-41-4-257]). Sox2 has been reported to bind to an upstream sequence of the human *NF2* promoter to repress transcription of the *NF2* gene in human osteocarcinoma cells ([@b5-molce-41-4-257]). In accord with this, a *Sox2* deficiency in the mouse retina was shown to result in the expansion of Nf2-positive CM cells into the retinal territory, indicating that Sox2 is necessary for suppressing the expression of *Nf2* in RPCs ([@b51-molce-41-4-257]). The ectopic CM population in the *Sox2*-deficient mouse retina was also shown to be positive for Yap/Taz, suggesting the alternative possibility that Sox2 blocks the expression of *Nf2* indirectly by inhibiting Yap/Taz expression.

FUNCTION OF NF2 AND YAP/TAZ IN THE CM AND CM-DERIVED NASCENT RPCS
=================================================================

The functions of YAP/TAZ in stem cell maintenance have been described in various experimental systems ([@b4-molce-41-4-257]; [@b42-molce-41-4-257]; [@b54-molce-41-4-257]). The mammalian CM has been shown to give rise to the cells in the peripheral retina and ciliary epithelial progeny in the CB and iris, at least during embryonic and perinatal periods of eye development ([@b7-molce-41-4-257]; [@b46-molce-41-4-257]). Mouse CM cells express Yap/Taz at higher levels compared with the moderate Yap/Taz expression in early RPCs, suggesting that high Yap/Taz activity is required for maintaining the stemness and bipotency of CM progenitors and the antagonistic activity of the Hippo pathway toward them. In support of this, nascent RPCs derived from *Nf2*-deficient CM progenitors do not differentiate into neurons in the perinatal mouse retina, but simply expand themselves in association with persistent nuclear accumulation of Yap/Taz. However, the *Nf2*-deficient RPC population eventually ceases to accumulate and is depleted after post-nataly day 14 (*Moon et al., unpublished data*). These results are in agreement with research on frog CM stem cells ([@b12-molce-41-4-257]). In the adult frog CM, Yap is specifically expressed in active neural stem cells within the retina. Furthermore, Yap loss-of-function or gain-of-function analyses suggest that Yap is essential for proper cell cycle progression, but is dispensable for stem cell maintenance ([Fig. 3](#f3-molce-41-4-257){ref-type="fig"}).

CONCLUSION
==========

Hippo signaling activity is tightly regulated during eye development such that dysregulation of Hippo signaling activity leads to severe ocular lesions owing to defects in the coordination of optic tissue growth. Recent studies have revealed that NF2, an upstream regulator of the Hippo signaling pathway, plays a crucial in eye development by differentiating the growth profile of the optic neuroepithelium, establishing the epithelial rigidity of the RPE/CM population, and maintaining proper Yap/Taz activity during the transition of CM-derived, nascent RPCs. Further research is required to reveal how the NF2-Hippo-Yap singling pathway is integrated with the multiple regulatory networks that control the eye development, including Wnt/β-catenin, BMP, and Notch pathways.
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![Divergent development of mouse optic neuroepithelial continuum\
The neuroepithelium in mouse embryonic ventral diencephalon evaginates laterally to form the optic vesicle (OV), which then invaginates to form double-layered optic cup by E12.5. The proliferation rate of neuroepithelium in the OV is highest in the distal part, which is specified into primitive neural retina (pNR) (left). In the optic cup of mouse embryonic eye, the proliferation rate is displayed more diversely. Post-mitotic RPE cells form a monolayer sheet, while RPCs in the NR actively proliferate to produce retinal neurons (middle). The CM is specified in the border between the NR and RPE, and the cells in the CM proliferate moderately. The CM area further develops to form the ciliary body (CB) in the post-natal eye. The cells in the outer layer of CM/CB are pigmented, whereas those in the inner CM/CB layer are non-pigmented. The ciliary epithelium (CE) comprising the CB proliferates in the post-natal days, when majority cells in the NR become post-mitotic (right), and this drives the growth of the eye.](molce-41-4-257f1){#f1-molce-41-4-257}

![Specification and growth of the CM and CB\
The CM is specified by Wnt-βCtn signaling in the edge of the double-layered OC of the midgestation mouse embryo. In late embryonic mouse eyes, RPCs receive Shh signals from RGCs, in addition to self-maintaining Notch signals, and sustain their proliferation at a high rate. Lrp2 expressed in CM cells prevents Shh from activating their proliferation, maintaining a lower proliferation rate in CM cells than in RPCs. In the post-natal mouse eye, the CM starts to form folds that develop into the CB with the help of autocrine BMPs, which are indirectly activated by Notch signals.](molce-41-4-257f2){#f2-molce-41-4-257}

![The NF2-Hippo-Yap/Taz pathway regulates the differential growth of optic neuroepithelial compartments\
*Nf2* expression is differentially regulated in the optic neuroepithelial continuum, which shows regional differentiation of proliferation rates. In the post-mitotic RPE, Mitf induces *Nf2* expression by directly binding to upstream sequences of the *Nf2* gene, triggering Hippo signaling and thereby excluding Yap/Taz from the nucleus. In proliferating RPCs, Sox2 inhibits the expression of *Nf2* and, as a consequence, impedes Hippo signaling activity. In CM progenitors, which have the potential to give rise to RPCs and RPE in addition to developing locally into the CB and iris, Yap/Taz is localized to the nucleus, where it induces the expression of *Nf2*, thereby establishing the NF2-Hippo-Yap/Taz signaling cascade. This feedback regulatory circuit maintains a level of proliferation in CM cells intermediate between that of the RPE and RPCs.](molce-41-4-257f3){#f3-molce-41-4-257}
